Updated Jul 16, 2026
Martin Samuel Bates has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Martin Samuel Bates is a name that appears in SEC filings linked to Celldex Therapeutics, Inc. as of 2026-06-29. Publicly available biographical information about this individual is limited, and the filings do not, by themselves, confirm a specific current role, career history, or detailed background. The context suggests a connection to Celldex in an insider or related capacity, but without additional corroborating sources, a precise biography cannot be established. If you have a particular filing (e.g., Form 3/4/5) or a link to the company’s leadership page mentioning this person, I can help interpret the details.
| Role | Insider |
|---|---|
| Notability | 15/100 |
Martin Samuel Bates is a name that appears in SEC filings linked to Celldex Therapeutics, Inc. as of 2026-06-29. Publicly available biographical information about this individual is limited, and the filings do not, by themselves, confirm a specific current role, career history, or detailed background. The context suggests a connection to Celldex in an insider or related capacit…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Martin Samuel Bates profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.